Merck to pay out C$6.375 million to Canadians who took Fosamax. For those unaware, Fosamax is believed to increase the risk of developing atypical femur fractures and osteonecrosis of the jaw – which is also known as “jawbone death.”
This continues Merck’s recent pattern of settling lawsuits (NuvaRing, US Fosamax, etc.), a move that is in striking contrast to the legal wars they waged against Vioxx victims years ago.
Read it here: